Table 2 Summary of effect of cinacalcet on biochemical parameters.

From: Cinacalcet versus Placebo for secondary hyperparathyroidism in chronic kidney disease patients: a meta-analysis of randomized controlled trials and trial sequential analysis

Outcomes

subgroup

No of patients (studies)

RR or SMD [95% CI]

p for RR or SMD

heterogeneity I2% (p)

effects model

heterogeneity for subgroup I2% (p)

RIS

Description of TSA graph: cumulative Z curve crossed the TSA boundaries

PTH reduction ≥ 30%

all

3683 (14)

2.46 [1.59, 3.81]

<0.0001

95 (<0.00001)

random

0 (0.76)a

2092

yes

dialysis

3237 (12)

2.42 [1.48, 3.97]

0.0004

96 (<0.00001)

random

 

2403

yes

none of two

446 (2)

2.65 [1.96, 3.58]

<0.00001

0 (0.76)

random

 

NA

NA

achieved serum PTH target

all

3589 (13)

3.03 [1.78, 5.17]

<0.0001

94 (<0.00001)

random

83.5 (0.01)a

2293

yes

dialysis

3197 (12)

2.74 [1.61, 4.67]

0.0002

93 (<0.00001)

random

 

2294

yes

none of two

392 (1)

10.98 [4.17, 28.92]

<0.00001

NA

random

 

NA

NA

end of treatment serum PTH

all

3100 (12)

−0.67 [−0.90, −0.44]

<0.00001

88 (<0.00001)

random

0 (0.65)

1272

yes

dialysis

2785 (10)

−0.68 [−0.95, −0.41]

<0.00001

90 (<0.00001)

random

0 (0.84)a

1370

yes

renal transplant

114 (1)

−0.50 [−0.88, −0.13]

0.008

NA

random

0 (0.44)b

NA

NA

none of two

201 (1)

−0.73 [−1.04, −0.41]

<0.00001

NA

random

0 (0.38)c

NA

NA

end of treatment serum calcium (Ca)

all

2623 (14)

−1.07 [−1.30, −0.84]

<0.00001

84 (<0.00001)

random

93.5 (<0.00001)

399

yes

dialysis

2176 (11)

−0.93 [−1.13, −0.74]

<0.00001

73 (0.0001)

random

0 (0.5)a

314

yes

renal transplant

114 (1)

−2.41 [−2.90, −1.92]

<0.00001

NA

random

96.7 (<0.00001)b

NA

NA

none of two

333 (2)

−1.13 [−1.66, −0.60]

<0.0001

58 (0.12)

random

91.8 (0.0005)c

NA

NA

end of treatment serum phosphorous (P)

all

3366 (14)

−0.03 [−0.24, 0.17]

0.75

86 (<0.00001)

random

97.4 (<0.00001)

51194

no

dialysis

2918 (11)

−0.21 [−0.29, −0.14]

<0.00001

26 (0.20)

fixed

96.9 (<0.00001)a

1937

yes

renal transplant

114 (1)

1.28 [0.88, 1.69]

<0.00001

NA

random

98 (<0.00001)b

NA

NA

none of two

334 (2)

0.53 [0.29, 0.77]

<0.0001

0 (0.83)

fixed

90 (0.002)c

NA

NA

end of treatment calcium by phosph- orous product (Ca*P)

all

3005 (11)

−0.49 [−0.67, −0.32]

<0.00001

77 (<0.00001)

random

97 (<0.00001)a

2606

yes

dialysis

2613 (10)

−0.57 [−0.65, −0.49]

<0.00001

9 (0.36)

fixed

 

293

yes

none of two

392 (1)

0.15 [−0.08, 0.38]

<0.00001

NA

random

 

NA

NA

Achieved (Ca*P) target

dialysis

1223 (5)

1.33 [1.20, 1.47]

<0.00001

45 (0.12)

fixed

 

1470

yes

  1. NA: not available, a: subgroup dialysis vs subgroup none of two, b: subgroup dialysis vs renal transplant, c: subgroup renal transplant vs none of two, RR: risk ratio, SMD: standardized mean difference, CI: confidence intervals, RIS: required information size, TSA: trial sequential analysis.